SEC Form 4 · accession 0001140361-16-072219
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Eric Davis
Officer — EVP, General Counsel
Period of report
Jun 16, 2016
Accepted (ET)
Jul 11, 2016 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 16, 2016 | G | 120 | $0.00 | D | 72,836 | D | |
| Common StockF2,F3 | Jul 7, 2016 | S | 2,167 | $90.00 | D | 70,669 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 16, 2016, the reporting person gifted 120 shares to an educational institution.
- F2Trade made pursuant to a 10b5-1 plan executed on June 14, 2016.
- F3All shares were sold at exactly $90.00.